23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ME | AMGN | VRTX | REGN | BMY |
| Company | 23Andme Holding Co. | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5082 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 0.5288 | 279.84 | 406.95 | 913.21 | 44.47 |
| Low | 0.4931 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 0.5002 | 278.68 | 403.41 | 906.71 | 44.23 |
| Change | -0.0020 | +4.74 | +10.60 | +16.05 | +0.29 |
| % Change | -0.40% | +1.73% | +2.70% | +1.80% | +0.66% |
| Volume | 2,677,701 | 1,338,020 | 733,228 | 302,859 | 9,545,304 |
| 20-Day Average Volume | 7,201,415 | 2,182,108 | 968,629 | 459,513 | 13,835,650 |
| Previous Close | 0.5022 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4653 | 269.77 | 399.06 | 909.51 | 48.22 |
| 20-Day Raw Stochastic | 63.27% | 99.78% | 65.60% | 41.30% | 7.62% |
| 20-Day Relative Strength | 51.67% | 54.13% | 50.12% | 45.55% | 29.57% |
| Weighted Alpha | -74.56 | +15.46 | +15.98 | +18.52 | -35.92 |
| Today's Opinion | 64% Sell | 16% Sell | 8% Buy | 24% Buy | 88% Sell |
| Previous Opinion | 80% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 88% Sell | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.37% since 04/24/24 | +2.18% since 04/24/24 | +1.11% since 04/24/24 | +0.51% since 04/24/24 | -9.20% since 04/24/24 |
| Low | 0.4501 on 04/25/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.5288 on 05/01/24 | 279.00 on 05/01/24 | 405.72 on 05/01/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -1.29% since 04/01/24 | -1.44% since 04/01/24 | -3.63% since 04/01/24 | -6.00% since 04/01/24 | -16.28% since 04/01/24 |
| Low | 0.3500 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.6190 on 04/18/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -28.50% since 02/01/24 | -14.05% since 02/01/24 | -6.61% since 02/01/24 | -4.87% since 02/01/24 | -8.85% since 02/01/24 |
| Low | 0.3500 on 04/17/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 0.8260 on 02/16/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -36.56% since 11/01/23 | +6.95% since 11/01/23 | +9.71% since 11/01/23 | +15.15% since 11/01/23 | -13.48% since 11/01/23 |
| Low | 0.3500 on 04/17/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 1.0200 on 12/14/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 242,521 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 482,917 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 299,490,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -311,660,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 44,750,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -277,980,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.27 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 02/07/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/23/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |